• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination

    3/25/26 6:03:49 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $IPEX alert in real time by email

    SINGAPORE and NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- GOWell Technology Limited ("GOWell" or the "Company"), a global one-stop-shop for innovative well logging solutions in the energy sector, and Inflection Point Acquisition Corp. V (NASDAQ:IPEX) ("Inflection Point"), a special purpose acquisition company, have announced the public filing of their joint registration statement on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") related to their previously announced business combination (the "Business Combination").

    The Registration Statement contains a preliminary proxy statement/prospectus of Inflection Point that discloses important information about Inflection Point, GOWell and the Business Combination, including a business overview of GOWell, terms of the Business Combination, pro forma financial information of the combined company, and risk factors. The Registration Statement has not yet been declared effective by the SEC, and the information contained therein is subject to change. The Registration Statement was officially filed with the SEC on March 23, 2026, and can be viewed on the SEC's website at www.sec.gov. For the direct link to the Form F-4 filing, visit: https://www.sec.gov/ix?doc=/Archives/edgar/data/0002097557/000121390026033178/ea0268687-03.htm.

    Upon the closing of the Business Combination, the combined company will be named GOWell Energy Technology and will be listed on the Nasdaq under the ticker symbol "GOW". The Business Combination is expected to close in the first half of 2026, subject to customary closing conditions, including regulatory and stockholder approvals.

    About GOWell Technology Limited

    GOWell Technology Limited is an international company that provides a wide range of innovative well logging technologies and distributed sensing solutions for energy companies globally. The Company maintains a multi-disciplinary research and development team with a robust patent portfolio of technology aimed to solve complex industry challenges. GOWell's solutions can be applied to a wide range of wells from traditional energy to energy transition. The Company has a global, diverse customer base with long-term relationships with the key major oil service companies and operators in the energy sector. Headquartered in Singapore, GOWell has a global manufacturing and procurement network, with regional hubs in the United States and UAE in addition to regional operations in more than 50 countries.

    For more information about GOWell Technology Limited, visit www.gowell.energy.

    About Inflection Point Acquisition Corp V.

    Inflection Point Acquisition Corp. V is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.

    Contact:

    Investor Relations Contact:

    Gateway Group

    Cody Slach, Georg Venturatos

    949-574-3860

    [email protected]

    Media Relations Contact:

    Gateway Group

    Zach Kadletz, Ryan Deloney

    949-574-3860

    [email protected]



    Primary Logo

    Get the next $IPEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IPEX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IPEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GOWell to Host Investor & Analyst Webinar on April 14, 2026

    SINGAPORE and NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- GOWell Technology Limited ("GOWell" or the "Company"), a global one-stop-shop for innovative well logging solutions in the energy sector, will host an Investor & Analyst Webinar on Tuesday, April 14, 2026 at 10:00 a.m. ET. The webinar will include a formal presentation and Q&A session with management. The Company previously announced that it had entered into a Business Combination Agreement with Inflection Point Acquisition Corp. V (NASDAQ:IPEX) ("IPEX"), on October 14, 2025. To register for this webinar, please use the registration link found here. Additionally, for those unable to listen to the live webcast, a recording will be

    3/31/26 6:00:00 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination

    SINGAPORE and NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- GOWell Technology Limited ("GOWell" or the "Company"), a global one-stop-shop for innovative well logging solutions in the energy sector, and Inflection Point Acquisition Corp. V (NASDAQ:IPEX) ("Inflection Point"), a special purpose acquisition company, have announced the public filing of their joint registration statement on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") related to their previously announced business combination (the "Business Combination"). The Registration Statement contains a preliminary proxy statement/prospectus of Inflection Point that discloses importan

    3/25/26 6:03:49 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GOWell Technology Participates in Advanced Well Integrity Benchmarking Program Coordinated by an Independent Net Zero Organization

    SINGAPORE and NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- GOWell Technology Limited ("GOWell" or the "Company"), a global one-stop-shop for innovative well logging solutions in the energy sector, today announced its participation in a collaborative effort to evaluate next generation well integrity technologies. The evaluation was performed as part of an industry benchmarking program led by an independent Net Zero organization at the NORCE testing facility in Stavanger, Norway. This initiative assessed cutting-edge methods designed to address the industry's most urgent operational and sustainability challenges in well integrity evaluation. As global decommissioning activities accelerate, o

    12/18/25 8:30:00 AM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $IPEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Trabuco Carolyn

    3 - Inflection Point Acquisition Corp. V (0002028355) (Issuer)

    1/20/26 5:01:12 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Executive Officer Blitzer Michael

    4 - Inflection Point Acquisition Corp. V (0002028355) (Issuer)

    1/5/26 9:41:33 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $IPEX
    SEC Filings

    View All

    SEC Form 425 filed by Inflection Point Acquisition Corp. V

    425 - Inflection Point Acquisition Corp. V (0002028355) (Subject)

    4/14/26 9:05:21 AM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Inflection Point Acquisition Corp. V filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Inflection Point Acquisition Corp. V (0002028355) (Filer)

    4/14/26 9:00:26 AM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 425 filed by Inflection Point Acquisition Corp. V

    425 - Inflection Point Acquisition Corp. V (0002028355) (Subject)

    4/3/26 4:21:11 PM ET
    $IPEX
    Biotechnology: Pharmaceutical Preparations
    Health Care